Trials / Completed
CompletedNCT02717780
Short Life Agents in Balanced Anesthesia on Obstructive Sleep Apnea Syndrome
Respiratory Impact of Short Life Agents Used in Balanced Anesthesia on Patients Suffering or Suspected of Obstructive Sleep Apnea (OSA) Syndrome
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Centre Hospitalier Universitaire Vaudois · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators aim to assess the respiratory effect of short half-life agents in balanced anesthesia on patients suffering from non-treated or suspected obstructive sleep apnea syndrome (OSA) We will study the impact on OSA of a regimen of remifentanil-desflurane versus a regimen of fentanyl-sevoflurane. Each patient will undergo three respiratory portable polygraphies: the night before the surgery ; the first night following the surgery ; the third night following the surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fentanyl and sevoflurane | |
| DRUG | Remifentanil and desflurane |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2018-06-01
- Completion
- 2018-06-01
- First posted
- 2016-03-24
- Last updated
- 2018-07-18
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT02717780. Inclusion in this directory is not an endorsement.